16-LB: Effects of Finerenone in Patients with CKD and T2D Are Independent of HbA1c at Baseline, HbA1c Variability, and Duration of Diabetes - Publikationer

Institut for Idræt og Ernæring

16-LB: Effects of Finerenone in Patients with CKD and T2D Are Independent of HbA1c at Baseline, HbA1c Variability, and Duration of Diabetes

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt

Janet B. Mcgill
Rajiv Agarwal
Stefan Anker
George Bakris
Gerasimos Filippatos
Bertram Pitt
Luis M. Ruilope
Andreas L. Birkenfeld
Luiza Caramori
Meike Daniela Brinker
Amer Joseph
Andrea Z. Lage
Robert Lawatscheck
Charlie Scott
Rossing, Peter

Originalsprog	Engelsk
Artikelnummer	16-LB
Tidsskrift	Diabetes
Vol/bind	71
Udgave nummer	Supplement_1
ISSN	0012-1797
DOI	https://doi.org/10.2337/db22-16-LB
Status	Udgivet - 2022

ID: 344849017